Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ALXOCompany Name
ALX ONCOLOGY HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALX ONCOLOGY HOLDINGS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALXO - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 0 | $ 20.16M | 0% |
| 3/31/2025 | $ 0 | $ 25.28M | 0% |
| 12/31/2024 | $ 0 | $ 27.09M | 0% |
| 9/30/2024 | $ 0 | $ 27.96M | 0% |
| 6/30/2024 | $ 0 | $ 27.97M | 0% |
| 3/31/2024 | $ 0 | $ 26.95M | 0% |
| 12/31/2023 | $ 0 | $ 26.27M | 0% |
| 9/30/2023 | $ 0 | $ 25.85M | 0% |
| 6/30/2023 | $ 0 | $ 25.09M | 0% |
| 3/31/2023 | $ 0 | $ 24.69M | 0% |
Key Performance Insights, Last 5 Years
- ALX ONCOLOGY HOLDINGS INC's latest trailing twelve months (TTM) SB Comp % stands at 459.9%.
- Over the past 5 years, ALX ONCOLOGY HOLDINGS INC's average SB Comp % has been 902.15%.
- The median SB Comp % for ALX ONCOLOGY HOLDINGS INC during this period was 902.15%
- ALX ONCOLOGY HOLDINGS INC reached its highest SB Comp % over the past 5 years at 1344.4%.
- The lowest SB Comp % recorded by ALX ONCOLOGY HOLDINGS INC in the same timeframe 459.9%
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for ALX ONCOLOGY HOLDINGS INC is calculated as follows: SB Comp. [ $ 5.44M ] / Revenues [ $ 1.18M ]
(=) SB Comp % [ 459.9% ] ALXO - Stock Based Compensation Margin, Last 5 years
459.9%
Minimum
Dec 31, 2020
1344.4%
Maximum
Mar 31, 2021
902.15%
Average
902.15%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |